Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Open-label, Multiple Ascending Dose Basket Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Select Autoimmune Rheumatic Diseases

NCT06647069 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06647069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06647069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Open-label, Multiple Ascending Dose Basket Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Select Autoimmune Rheumatic Diseases
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Recruiting
Start date
March 27, 2025
Completion date
June 25, 2029
Enrollment
62 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra), systemic lupus erythematosus (sle)